Leonteq Securities AG Buys New Position in Intuitive Surgical, Inc. $ISRG

Leonteq Securities AG bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, Holdings Channel reports. The institutional investor bought 6,526 shares of the medical equipment provider’s stock, valued at approximately $3,696,000.

Several other institutional investors have also recently added to or reduced their stakes in the company. Holos Integrated Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $25,000. Newbridge Financial Services Group Inc. increased its stake in shares of Intuitive Surgical by 300.0% during the 4th quarter. Newbridge Financial Services Group Inc. now owns 44 shares of the medical equipment provider’s stock valued at $25,000 after acquiring an additional 33 shares during the last quarter. Greykasell Wealth Strategies Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $27,000. Olistico Wealth LLC acquired a new position in shares of Intuitive Surgical during the 4th quarter valued at about $28,000. Finally, Caitlin John LLC acquired a new position in shares of Intuitive Surgical during the 3rd quarter valued at about $30,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG opened at $449.03 on Thursday. The firm has a 50 day moving average price of $460.63 and a 200 day moving average price of $511.79. The company has a market cap of $159.03 billion, a PE ratio of 54.43, a price-to-earnings-growth ratio of 3.53 and a beta of 1.51. Intuitive Surgical, Inc. has a 1 year low of $417.74 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.08 by $0.42. The firm had revenue of $2.77 billion during the quarter, compared to the consensus estimate of $2.62 billion. Intuitive Surgical had a net margin of 28.15% and a return on equity of 15.98%. The company’s revenue was up 23.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.81 EPS. On average, sell-side analysts predict that Intuitive Surgical, Inc. will post 8.57 earnings per share for the current year.

Insider Activity

In related news, SVP Mark Brosius sold 645 shares of the stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $485.01, for a total transaction of $312,831.45. Following the completion of the sale, the senior vice president owned 1,613 shares of the company’s stock, valued at approximately $782,321.13. This represents a 28.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 105 shares of the company’s stock in a transaction that occurred on Tuesday, March 10th. The stock was sold at an average price of $493.95, for a total value of $51,864.75. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 5,683 shares of company stock worth $2,775,891. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have recently commented on ISRG. Evercore dropped their price objective on shares of Intuitive Surgical from $550.00 to $480.00 and set a “neutral” rating for the company in a research note on Monday, April 6th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research note on Tuesday. HSBC dropped their price objective on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Mizuho set a $525.00 price objective on shares of Intuitive Surgical and gave the company a “neutral” rating in a research note on Monday, April 13th. Finally, Truist Financial dropped their price objective on shares of Intuitive Surgical from $650.00 to $580.00 and set a “buy” rating for the company in a research note on Wednesday, April 15th. Nineteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $579.33.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.